Cystic hygroma is a rare congenital malformation caused by abnormal development of lymphatic vessels. It is usually diagnosed during pregnancy, often in the second trimester. The condition is characterized by a fluid-filled sac that is located in the neck, chest, or abdomen. Cystic hygroma can cause a variety of symptoms, including difficulty breathing, respiratory distress, and even cardiac problems. Ultrasound is the primary imaging modality used to diagnose cystic hygroma, as it can provide detailed images of the affected area. In this article, we will discuss the ultrasound features of cystic hygroma, as well as the implications for patient care.
Cystic hygroma is a rare congenital malformation caused by abnormal development of lymphatic vessels. It is usually diagnosed during pregnancy, often in the second trimester. The condition is characterized by a fluid-filled sac that is located in the neck, chest, or abdomen. Cystic hygroma can cause a variety of symptoms, including difficulty breathing, respiratory distress, and even cardiac problems.
Ultrasound is the primary imaging modality used to diagnose cystic hygroma, as it can provide detailed images of the affected area. On ultrasound, cystic hygroma appears as a large, fluid-filled cyst with a thin wall. The cyst may be located in the neck, chest, or abdomen. It may also be associated with other anomalies, such as cardiac defects or skeletal abnormalities. The size of the cyst can vary, but it is typically larger than 5 cm in diameter. It may also have septations, which are thin walls that divide the cyst into smaller compartments. The cyst may also contain debris, which may appear as echogenic material on ultrasound.
The diagnosis of cystic hygroma has important implications for patient care. If the condition is detected during pregnancy, the patient should be closely monitored for any signs of respiratory distress or cardiac problems. In addition, the patient should be referred to a specialist for further evaluation and management. If cystic hygroma is detected after birth, the patient should be referred to a specialist for further evaluation and management. Treatment may include surgical removal of the cyst or drainage of the cyst with a needle. In some cases, medications may be used to reduce the size of the cyst.
Cystic hygroma is a rare congenital malformation caused by abnormal development of lymphatic vessels. Ultrasound is the primary imaging modality used to diagnose cystic hygroma, as it can provide detailed images of the affected area. The diagnosis of cystic hygroma has important implications for patient care, and patients should be referred to a specialist for further evaluation and management. Treatment may include surgical removal of the cyst or drainage of the cyst with a needle, as well as medications to reduce the size of the cyst.
1.
When Should Immunocompromised Individuals Receive a COVID Booster?
2.
Home Screening Appeals to Women Facing Healthcare Barriers
3.
Quality of Life Similar With Proton Beam Therapy vs IMRT for Prostate Cancer
4.
Prolonged Screen Time Linked to Sleep Issues in Preschoolers
5.
Precision Medicine in mHSPC: Integrating Novel Biomarkers, Imaging, and Emerging Targeted Agents
1.
Rehabilitation After Organ-Conserving Cancer Surgery
2.
Revolutionizing Oncology: AI in Radiology, Machine Learning in Pathology, and Deep Learning for Cancer Detection
3.
Artificial Intelligence for Bone Marrow Cellular Ecosystem Modeling
4.
Thyroid Cancer and Insulin Resistance: Unraveling the Complex Interplay for Better Patient Outcomes
5.
Mastering Breast Cancer Care in 2025: Diagnosis, Treatment, Education, and Innovation
1.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
2.
International Cancer Conference
3.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
4.
Asian Symposium on Advancement in Hematology and Oncology
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Navigating the Complexities of Ph Negative ALL - Part XIII
2.
Treatment Paradigm for Patients with R/R Adult B-cell ALL- Expert Discussions
3.
Pazopanib Takes Center Stage in Managing Renal Cell Carcinoma - Part I
4.
Pazopanib Takes Center Stage in Managing Renal Cell Carcinoma - Part III
5.
CNS Clarity from Day One: Rethinking Early Diagnostic Strategies in ALK+NSCLC
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation